1263: Top 5 Most Read RNS's on Vox Markets for Wednesday 15th March 2023

The Vox Markets Podcast

Top 5 Most Read RNS's on Vox Markets for Wednesday 15th March 2023
5. TruFin #TRU - Final Results for the year ended 31 December 2022

Gross revenues grew 23% to £16.1m (2021: £13.1m) driven by significant revenue growth from three out of four subsidiaries
- Recurring software and licensing fees represented 84% of revenue (2021: 87%)
- Gross profit margin grew to 69% (2021: 53%)
- Loss Before Tax ("LBT") was £8.0m (2021: £8.4m)
- Cash and cash equivalents at year end totalled £10.3m (£3.9m unrestricted)
4. Quantum Blockchain Technologies #QBT - Update on Sipiem Court Appeal

In the Company's announcement of 1 November 2022, the Venice Court ruled in favour of CL17 (QBT's wholly owned subsidiary) for an aggregate amount of €6,188,974 (plus interest and adjustments for inflation to accrue from different dates until the date of payment) in damages, plus €85,499 in legal expenses.
The Company is pleased to report that the Appeal Court has ruled in favour of CL17 thereby allowing it to seek enforcement of the Award Payment against the main Sipiem defendant.
3. Atlantic Lithium #ALL - Corporate Update and Half-year Financial Report

Project Highlights
· Completed Pre-Feasibility Study on the Ewoyaa Lithium Project, demonstrating the significant profitability potential of this stand-out project:
o LOM revenues exceeding US$4.84bn, Post-tax NPV8 of US$1.33bn, IRR of 224% over 12.5 years
o US$125m capital cost with industry-leading payback period of <5 months
2. Reabold Resources #RBD - Statement regarding recent speculation

The Company notes the speculation in a recent website report and confirms that it has received an unsolicited approach from Kamran Sattar on behalf of Portillion SPV O&G (which, whilst no such company of that name is incorporated in the United Kingdom, the Company believes is an affiliate of Portillion Capital Limited), which may or may not lead to an offer being made for the entire issued and to be issued ordinary share capital of the Company.
This highly preliminary approach was made yesterday at 4.46 p.m. (London time) via a succinct email, with no details included, save for it referring to a possible offer price at a 10% premium to yesterday's closing price, implying a value of 0.2035 pence per ordinary share.
Even in the absence of further information, the Board believes that the Possible Offer Price significantly undervalues Reabold's investment portfolio, the Company as a whole, and its future prospects. Shareholders are advised to take no action in respect of the possible offer at this stage.
1. Versarien #VRS - Placing to raise £318,000

Versarien announces it has raised £318,000 by way of a placing at a price of 3 pence per share, the closing price yesterday was 3.75p.